JP2013532130A5 - - Google Patents

Download PDF

Info

Publication number
JP2013532130A5
JP2013532130A5 JP2013510364A JP2013510364A JP2013532130A5 JP 2013532130 A5 JP2013532130 A5 JP 2013532130A5 JP 2013510364 A JP2013510364 A JP 2013510364A JP 2013510364 A JP2013510364 A JP 2013510364A JP 2013532130 A5 JP2013532130 A5 JP 2013532130A5
Authority
JP
Japan
Prior art keywords
represented
compound
pharmaceutically acceptable
acceptable salt
structural formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013510364A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013532130A (ja
JP5715241B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/036701 external-priority patent/WO2011143669A2/en
Publication of JP2013532130A publication Critical patent/JP2013532130A/ja
Publication of JP2013532130A5 publication Critical patent/JP2013532130A5/ja
Application granted granted Critical
Publication of JP5715241B2 publication Critical patent/JP5715241B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013510364A 2010-05-14 2011-05-16 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 Active JP5715241B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US33499110P 2010-05-14 2010-05-14
US61/334,991 2010-05-14
US37074510P 2010-08-04 2010-08-04
US61/370,745 2010-08-04
US37586310P 2010-08-22 2010-08-22
US61/375,863 2010-08-22
PCT/US2011/036701 WO2011143669A2 (en) 2010-05-14 2011-05-16 Compositions and methods for treating neoplasia, inflammatory disease and other disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015049960A Division JP5937247B2 (ja) 2010-05-14 2015-03-12 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法

Publications (3)

Publication Number Publication Date
JP2013532130A JP2013532130A (ja) 2013-08-15
JP2013532130A5 true JP2013532130A5 (no) 2014-11-06
JP5715241B2 JP5715241B2 (ja) 2015-05-07

Family

ID=49052897

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013510364A Active JP5715241B2 (ja) 2010-05-14 2011-05-16 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法
JP2015049960A Active JP5937247B2 (ja) 2010-05-14 2015-03-12 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015049960A Active JP5937247B2 (ja) 2010-05-14 2015-03-12 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法

Country Status (1)

Country Link
JP (2) JP5715241B2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130252331A1 (en) * 2010-05-14 2013-09-26 James Elliott Bradner Compositions and methods for modulating metabolism
BR122014024883A2 (pt) 2010-05-14 2019-08-20 Dana-Farber Cancer Institute, Inc. Compostos no tratamento de neoplasia
IN2014DN11269A (no) * 2012-06-25 2015-10-09 Oncoethix Sa
CN105899212A (zh) * 2013-08-06 2016-08-24 翁科埃斯克斯有限公司 利用β溴结构域抑制剂治疗弥漫性大B细胞淋巴瘤(DLBCL)的方法
CN105849110B (zh) * 2013-11-08 2019-08-02 达纳-法伯癌症研究所有限公司 使用溴结构域和额外终端(bet)蛋白抑制剂的用于癌症的组合疗法
RU2722179C2 (ru) 2014-02-28 2020-05-28 Тэнша Терапеутикс, Инк. Лечение состояний, ассоциированных с гиперинсулинемией
WO2016210275A1 (en) * 2015-06-26 2016-12-29 Tensha Therapeutics, Inc. Treatment of nut midline carcinoma
CA2996974A1 (en) * 2015-09-11 2017-03-16 Dana-Farber Cancer Institute, Inc. Cyano thienotriazolodiazepines and uses thereof
US10881668B2 (en) * 2015-09-11 2021-01-05 Dana-Farber Cancer Institute, Inc. Acetamide thienotriazolodiazepines and uses thereof
MA43037A (fr) * 2015-10-02 2018-08-08 Dana Farber Cancer Inst Inc Polythérapie par inhibiteurs de bromodomaine et blocage de point de contrôle
US11548899B2 (en) * 2016-02-15 2023-01-10 The Regents Of The University Of Michigan Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors
EP3555059A1 (en) * 2016-12-16 2019-10-23 H. Hoffnabb-La Roche Ag Process for the manufacture of diazepine derivatives
CN109503618A (zh) * 2017-09-14 2019-03-22 成都海创药业有限公司 一种brd4抑制剂
JP2021527136A (ja) * 2018-06-13 2021-10-11 ディブリー・アーゲー 縮合トリアゼピン誘導体の調製及びbet阻害剤としてのその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL330635A1 (en) * 1996-06-12 1999-05-24 Japan Tobacco Inc Inhibitor of cytokin production, triazepin compound and intermediate compounds used for obtaining the last mentioned one
US7589167B2 (en) * 2000-02-22 2009-09-15 J. David Gladstone Institutes ZA loops of bromodomains
MXPA05009151A (es) * 2003-02-27 2005-10-20 Abbott Lab Inhibidores de cinasa heterociclica.
KR101600634B1 (ko) * 2007-12-28 2016-03-07 미쓰비시 타나베 파마 코퍼레이션 항암제
RS54645B1 (en) * 2009-11-05 2016-08-31 Glaxosmithkline Llc BENZODIAZEPINE AS A BROMODOMEN INHIBITOR

Similar Documents

Publication Publication Date Title
JP2013532130A5 (no)
JP2011105738A5 (no)
JP2012107057A5 (no)
JP2012111758A5 (no)
JP2009149903A5 (no)
JP2011518833A5 (no)
JP2019194236A5 (no)
JP2012081521A5 (no)
JP2011510079A5 (no)
JP2013032389A5 (no)
JP2014221779A5 (no)
JP2009535462A5 (no)
JP2012255926A5 (no)
JP2011520976A5 (no)
JP2015522045A5 (no)
JP2013173781A5 (no)
JP2013541578A5 (no)
JP2011519871A5 (no)
JP2010529196A5 (no)
JP2011170856A5 (no)
JP2018521020A5 (no)
JP2012094862A5 (no)
JP2013532687A5 (no)
JP2011037885A5 (no)
JP2015199738A5 (no)